Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
暂无分享,去创建一个
B. Clarke | I. Shih | B. Rosen | Tian-Li Wang | D. Maeda | P. Shaw | A. Ayhan | R. Wu | Kyu-rae Kim | M. Chui
[1] Miguel Melo,et al. Frequency of TERT promoter mutations in human cancers , 2013, Nature Communications.
[2] A. von Deimling,et al. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma , 2013, Cell cycle.
[3] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[4] David T. W. Jones,et al. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. , 2013, The Lancet. Oncology.
[5] Gary L. Gallia,et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.
[6] D. Schadendorf,et al. TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.
[7] Honglin Zhou,et al. Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells. , 2012, Molecular cell.
[8] Tian-Li Wang,et al. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. , 2012, Journal of the National Cancer Institute.
[9] I. Shih,et al. Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma , 2012, International Journal of Gynecologic Cancer.
[10] H. Tsuda,et al. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations , 2012, Modern Pathology.
[11] David M Reynolds,et al. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. , 2012, Cell stem cell.
[12] P. Campbell. Telomeres and Cancer: From Crisis to Stability to Crisis to Stability , 2012, Cell.
[13] K. Kinzler,et al. Low‐grade serous carcinomas of the ovary contain very few point mutations , 2012, The Journal of pathology.
[14] H. Tsuda,et al. PIK3CA mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma , 2011, The Journal of pathology.
[15] E. Montgomery,et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. , 2011, The American journal of pathology.
[16] I. Shih,et al. Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma , 2011, Modern Pathology.
[17] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[18] Li-ping Guo,et al. The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells , 2011, Cancer biology & therapy.
[19] R. Beijersbergen,et al. EGFR overexpression induces activation of telomerase via PI3K/AKT‐mediated phosphorylation and transcriptional regulation through Hif1‐alpha in a cellular model of oral–esophageal carcinogenesis , 2011, Cancer science.
[20] I. Shih,et al. Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma , 2010, International journal of molecular sciences.
[21] Richard A. Moore,et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.
[22] Tian-Li Wang,et al. Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma , 2010, Science.
[23] T. de Lange. How Telomeres Solve the End-Protection Problem , 2009, Science.
[24] V. Velculescu,et al. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. , 2009, The American journal of pathology.
[25] Tatsuya Ozawa,et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.
[26] P. Schultz,et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations , 2009, Proceedings of the National Academy of Sciences.
[27] Y. Cong,et al. Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia‐inducible factor‐1α and the PI3K pathway , 2008, Journal of cellular biochemistry.
[28] M. Bellon,et al. Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. , 2008, Blood.
[29] D. Peeper,et al. Cellular senescence in vivo: a barrier to tumorigenesis. , 2008, Current opinion in cell biology.
[30] C. Harley,et al. Telomerase and cancer therapeutics , 2008, Nature Reviews Cancer.
[31] S. Kaye,et al. Ovarian clear cell adenocarcinoma: a continuing enigma , 2006, Journal of Clinical Pathology.
[32] A. Seth,et al. ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.
[33] Tsutomu Ohta,et al. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. , 2003, The American journal of pathology.
[34] S. Spiegl-Kreinecker,et al. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes , 2003, Melanoma research.
[35] J. Royds,et al. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme , 2003, The Lancet.
[36] R. Reddel,et al. Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.
[37] A. Sharrocks. The ETS-domain transcription factor family , 2001, Nature Reviews Molecular Cell Biology.
[38] M. Noguchi,et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. , 2000, Cancer research.
[39] S. Do,et al. Akt Protein Kinase Enhances Human Telomerase Activity through Phosphorylation of Telomerase Reverse Transcriptase Subunit* , 1999, The Journal of Biological Chemistry.
[40] R. Dalla‐Favera,et al. Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.
[41] F. Ishikawa. Telomere crisis, the driving force in cancer cell evolution. , 1997, Biochemical and biophysical research communications.
[42] D. McCance. Pathological Society of Great Britain and Ireland , 1984 .
[43] R. DePinho,et al. Telomeres and telomerase in cancer. , 2010, Carcinogenesis.
[44] P. Vercellini,et al. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. , 2006, Human reproduction update.
[45] D. Schadendorf,et al. Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2022 .